NPs Basic Information

Name
Phthalic acid
Molecular Formula C8H6O4
IUPAC Name*
phthalic acid
SMILES
C1=CC=C(C(=C1)C(=O)O)C(=O)O
InChI
InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)
InChIKey
XNGIFLGASWRNHJ-UHFFFAOYSA-N
Synonyms
phthalic acid; 88-99-3; 1,2-benzenedicarboxylic acid; o-phthalic acid; benzene-1,2-dicarboxylic acid; Pathalic acid; o-dicarboxybenzene; o-benzenedicarboxylic acid; Acide phtalique; PHTHALICACID; Kyselina ftalova; ortho-phthalic acid; Orthophthalic acid; MFCD00002467; Sunftal 20; CHEMBL1045; 6O7F7IX66E; CHEBI:29069; NSC-5348; Benzene-1,2-dicarboxylic Acid (Phthalic Acid); Acide phtalique [French]; Kyselina ftalova [Czech]; CCRIS 1446; HSDB 1339; NSC 5348; EINECS 201-873-2; BRN 0608199; UNII-6O7F7IX66E; Alizarinate; Naphthalinate; Phthalinate; Alizarinic acid; Phthalinic acid; Pathalc acd; AI3-02409; Naphthalinic acid; o-Carboxybenzoate; 4kww; phthalsäure; o-Carboxybenzoic acid; o-Benzenedicarboxylate; 1,2-benzenedioic acid; Phthalic acid, ~99%; WLN: QVR BVQ; Phthalate standard for IC; DSSTox_CID_1484; Phthalic acid, 99.5%; bmse000391; EC 201-873-2; PHTHALIC ACID [MI]; SCHEMBL1808; DSSTox_RID_76178; DSSTox_GSID_21484; PHTHALIC ACID [HSDB]; 4-09-00-03167 (Beilstein Handbook Reference); MLS002152931; PHTHALIC ACID [USP-RS]; DTXSID8021484; ZINC90750; NSC5348; HMS3039E17; HMS3604J03; Phthalic acid, analytical standard; BCP15370; HY-I0508; STR06656; Phthalic acid, reagent grade, 98%; Tox21_200915; BDBM50080272; PHTHALIC ACID [USP IMPURITY]; s6215; STL168879; AKOS000118898; DB02746; CAS-88-99-3; NCGC00090869-01; NCGC00090869-02; NCGC00258469-01; Phthalic acid, ACS reagent, >=99.5%; AC-14464; BP-21159; SMR001224528; CS-0009407; FLUORESCEIN IMPURITY B [EP IMPURITY]; FT-0622644; FT-0673874; P0287; Phthalic acid, SAJ first grade, >=99.0%; EN300-17992; Phthalic acid, SAJ special grade, >=99.0%; C01606; Phthalic acid, Vetec(TM) reagent grade, 98%; Phthalic acid, puriss. p.a., >=99.5% (T); AB-131/40237186; Q423876; FLUORESCEIN SODIUM IMPURITY B [EP IMPURITY]; J-523870; Z57127456; F3110-2832; Phthalic acid, European Pharmacopoeia (EP) Reference Standard; Phthalic acid, United States Pharmacopeia (USP) Reference Standard
CAS 88-99-3
PubChem CID 1017
ChEMBL ID CHEMBL1045
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Benzenoids
      • Class: Benzene and substituted d
        • Subclass: Benzoic acids and derivat
          • Direct Parent: Benzoic acids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 166.13 ALogp: 0.7
HBD: 2 HBA: 4
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 74.6 Aromatic Rings: 1
Heavy Atoms: 12 QED Weighted: 0.698

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.74 MDCK Permeability: 0.00001020
Pgp-inhibitor: 0 Pgp-substrate: 0.001
Human Intestinal Absorption (HIA): 0.071 20% Bioavailability (F20%): 0.005
30% Bioavailability (F30%): 0.897

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.399 Plasma Protein Binding (PPB): 53.42%
Volume Distribution (VD): 0.204 Fu: 34.12%

ADMET: Metabolism

CYP1A2-inhibitor: 0.039 CYP1A2-substrate: 0.043
CYP2C19-inhibitor: 0.043 CYP2C19-substrate: 0.039
CYP2C9-inhibitor: 0.111 CYP2C9-substrate: 0.058
CYP2D6-inhibitor: 0.037 CYP2D6-substrate: 0.055
CYP3A4-inhibitor: 0.022 CYP3A4-substrate: 0.025

ADMET: Excretion

Clearance (CL): 1.376 Half-life (T1/2): 0.91

ADMET: Toxicity

hERG Blockers: 0.108 Human Hepatotoxicity (H-HT): 0.361
Drug-inuced Liver Injury (DILI): 0.88 AMES Toxicity: 0.019
Rat Oral Acute Toxicity: 0.111 Maximum Recommended Daily Dose: 0.002
Skin Sensitization: 0.374 Carcinogencity: 0.01
Eye Corrosion: 0.02 Eye Irritation: 0.995
Respiratory Toxicity: 0.219
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000684 0.591 D07HBX 0.595
ENC000073 0.558 D0GY5Z 0.558
ENC000301 0.551 D0N3UL 0.500
ENC001356 0.458 D0Y0JH 0.466
ENC000299 0.458 D0F5ZM 0.423
ENC000348 0.455 D0G2MH 0.392
ENC000202 0.455 D0C4YC 0.356
ENC003916 0.453 D01WJL 0.356
ENC000544 0.450 D00KRE 0.353
ENC000108 0.439 D05FTJ 0.344
*Note: the compound similarity was calculated by RDKIT.